The changing epidemiology of hepatitis C virus infection in Europe
JI Esteban, S Sauleda, J Quer - Journal of hepatology, 2008 - Elsevier
The epidemic of hepatitis C virus (HCV) infection in Europe is continuously evolving and
epidemiological parameters (prevalence, incidence, disease transmission patterns and …
epidemiological parameters (prevalence, incidence, disease transmission patterns and …
Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review
D Prati - Journal of hepatology, 2006 - Elsevier
Hepatitis C virus (HCV) is a leading cause of chronic blood-borne infection and chronic liver
disease. The global epidemic of HCV infection emerged in the second half of the 20th …
disease. The global epidemic of HCV infection emerged in the second half of the 20th …
[HTML][HTML] Recommendations for the transfusion of red blood cells
G Liumbruno, F Bennardello, A Lattanzio… - Blood …, 2009 - ncbi.nlm.nih.gov
The transfusion of red cell concentrates (RCC) is indicated in order to achieve a fast
increase in the supply of oxygen to the tissues, when the concentration of haemoglobin (Hb) …
increase in the supply of oxygen to the tissues, when the concentration of haemoglobin (Hb) …
Infections and thalassaemia
S Vento, F Cainelli, F Cesario - The Lancet infectious diseases, 2006 - thelancet.com
Infections are major complications and constitute the second most common cause of
mortality and a main cause of morbidity in patients with thalassaemia, a group of genetic …
mortality and a main cause of morbidity in patients with thalassaemia, a group of genetic …
Hepatocellular carcinoma in the thalassaemia syndromes
C Borgna‐Pignatti, G Vergine… - British journal of …, 2004 - Wiley Online Library
Hepatocellular carcinoma (HCC) frequently complicates hepatic cirrhosis secondary to viral
infection or iron overload. Therefore, patients affected by thalassaemia syndromes have a …
infection or iron overload. Therefore, patients affected by thalassaemia syndromes have a …
Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C
E Minola, D Prati, F Suter, F Maggiolo… - Blood, The Journal …, 2002 - ashpublications.org
Before the introduction of hepatitis C virus (HCV) screening for blood donors, the risk of
acquiring HCV infection as a result of a transfusion was about 10%. The aim of this study …
acquiring HCV infection as a result of a transfusion was about 10%. The aim of this study …
[HTML][HTML] The transfusion management of beta thalassemia in the United States
The β thalassemia syndromes constitute the most frequent inherited anemia managed with
chronic red cell transfusions around the world. 1, 2 The prevalence of thalassemia in the …
chronic red cell transfusions around the world. 1, 2 The prevalence of thalassemia in the …
Blood transfusion and alloimmunization in patients with thalassemia: multicenter study
A Azarkeivan, S Ansari, MH Ahmadi… - Pediatric hematology …, 2011 - Taylor & Francis
One of transfusion's side effects is alloimmunization against red blood cell (RBC) antigens.
Early diagnosis by antibody screening is an important step in the detection of these …
Early diagnosis by antibody screening is an important step in the detection of these …
Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: a comprehensive review
HM Moukhadder, R Halawi, MD Cappellini, AT Taher - Cancer, 2017 - Wiley Online Library
The incidence of hepatocellular carcinoma (HCC) in patients with thalassemia is on the rise.
The 2 well recognized HCC risk factors in thalassemia are iron overload and chronic viral …
The 2 well recognized HCC risk factors in thalassemia are iron overload and chronic viral …
Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with …
PD Jensen, FT Jensen, T Christensen… - Blood, The Journal …, 2003 - ashpublications.org
The role of iron overload as cause of liver dysfunction has never been studied in detail in
patients without concomitant hepatotropic infections who receive multiple transfusions. We …
patients without concomitant hepatotropic infections who receive multiple transfusions. We …